Advertisement

Topics

MDM2 inhibitors could be promising new treatment for uveitis

20:00 EDT 31 Oct 2018 | AAAS

(University of North Texas Health Science Center) A new study from UNT Health Science Center shows that a class of drugs known as MDM2 inhibitors could lead to a promising new treatment for uveitis, which accounts for 10 percent of all cases of blindness in the United States.

Original Article: MDM2 inhibitors could be promising new treatment for uveitis

NEXT ARTICLE

More From BioPortfolio on "MDM2 inhibitors could be promising new treatment for uveitis"

Advertisement
Quick Search
Advertisement
Advertisement